Collectively, our data demonstrate that the compound TH588 which has been developed as an inhibitor of the 8-oxo-GTP hydrolyzing enzyme MTH1 impairs survival of cultured colon cancer cells and reduces viability of proliferating endothelial cells. The gene discussed is NUDT1; the disease is colonic neoplasm.